Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High-risk Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06494540
What this trial is testing

NIS to Examine the Effectiveness of TDC in Patients With Metastatic Non-squamous NSCLC and High-risk Genetic Alterations

Who this might be right for
Non-squamous Metastatic Non-Small-Cell Lung Carcinoma
AstraZeneca 600
Testing effectiveness (Phase 2)Looking for participantsNCT07120282
What this trial is testing

Study to Evaluate the Efficacy and Safety of Adjuvant Tislelizumab in High-Risk Stage I NSCLC

Who this might be right for
Lung Cancer (NSCLC)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 108
Testing effectiveness (Phase 2)Study completedNCT00409214
What this trial is testing

Phase IIa Safety and Light Dose-escalation Study in Patients With Primary or Recurrent/High-grade Glioma Using the Litx™ System to Confirm the Zone of Tumor Destruction During the Intraoperative Treatment of Glioma

Who this might be right for
GliomaGlioblastoma MultiformeAnaplastic Astrocytoma
Light Sciences Oncology 18
Testing effectiveness (Phase 2)Looking for participantsNCT06357676
What this trial is testing

Glofitamab Plus Ibrutinib With Obinutuzumab for the Treatment of Patients With Mantle Cell Lymphoma, IGNITE MCL Trial

Who this might be right for
Mantle Cell Lymphoma
OHSU Knight Cancer Institute 27
Large-scale testing (Phase 3)Study completedNCT00075725
What this trial is testing

Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic LeukemiaAdult B Acute Lymphoblastic LeukemiaChildhood B Acute Lymphoblastic Leukemia
Children's Oncology Group 3,154
Early research (Phase 1)Ended earlyNCT04116320
What this trial is testing

Focused Ultrasound Ablation and PD-1 Antibody Blockade in Advanced Solid Tumors

Who this might be right for
MelanomaBreast CancerMerkel Cell Carcinoma+10 more
Craig L Slingluff, Jr 5
Early research (Phase 1)Looking for participantsNCT07162038
What this trial is testing

Phase I Trial Integrating HLA-Haploidentical Anti-CD19 CAR-T Cells With Post-Transplantation Cyclophosphamide-Based HLA-Haploidentical Hematopoietic Cell Transplantation

Who this might be right for
Hematologic MalignanciesHematologic Neoplasms
National Cancer Institute (NCI) 155
Large-scale testing (Phase 3)Active Not RecruitingNCT05936658
What this trial is testing

[18F]Florastamin PET/CT Imaging Examination in Patients With Suspected Recurrent or Metastatic Prostate Cancer

Who this might be right for
High Risk Prostate Carcinoma
FutureChem 138
Not applicableEnded earlyNCT02221843
What this trial is testing

Sunbit UV Measuring Device to Track Sun Behavior

Who this might be right for
ImmunosuppressionSkin Neoplasms
University of Zurich 10
Early research (Phase 1)Ended earlyNCT01954784
What this trial is testing

Lenalidomide After Donor Stem Cell Transplant and Bortezomib in Treating Patients With High Risk Multiple Myeloma

Who this might be right for
Refractory Multiple MyelomaStage I Multiple MyelomaStage II Multiple Myeloma+1 more
Case Comprehensive Cancer Center 8
Testing effectiveness (Phase 2)Active Not RecruitingNCT04295447
What this trial is testing

Adjuvant Apalutamide in Subjects With High-risk Localized or Locally Advanced Prostate Cancer After Radical Prostatectomy

Who this might be right for
Prostatic Neoplasms
Universität Münster 190
Not applicableStudy completedNCT04847726
What this trial is testing

Contrast-enhanced Ultrasound With Perfluorobutane and Sulfur Hexafluoride for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Seoul National University Hospital 110
Testing effectiveness (Phase 2)Study completedNCT00003116
What this trial is testing

High-Dose Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+2 more
Case Comprehensive Cancer Center 66
Not applicableLooking for participantsNCT06204484
What this trial is testing

MRD-guided Deferred Adjuvant Therapy in Resectable Early-stage Colon Cancer

Who this might be right for
Colorectal Cancer
Sun Yat-sen University 349
Testing effectiveness (Phase 2)UnknownNCT05151549
What this trial is testing

Carilizumab Combined With Concurrent Chemoradiotherapy

Who this might be right for
Cervical Cancer
Hunan Cancer Hospital 46
Not applicableLooking for participantsNCT06687421
What this trial is testing

Implementation of Precision Medicine in High-risk Prostate Cancer

Who this might be right for
Prostate Cancer
Andreas Josefsson 5,500
Testing effectiveness (Phase 2)Looking for participantsNCT04899908
What this trial is testing

Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases

Who this might be right for
Brain CancerBrain MetastasesMelanoma+13 more
Brigham and Women's Hospital 134
Not applicableLooking for participantsNCT00040352
What this trial is testing

Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Melanoma

Who this might be right for
MelanomaDysplastic Nevus Syndrome
National Cancer Institute (NCI) 3,000
Post-approval studies (Phase 4)Study completedNCT00179478
What this trial is testing

Long Term Study of Avonex Therapy Following a First Attack of Multiple Sclerosis

Who this might be right for
Multiple SclerosisOptic NeuritisTransverse Myelitis+1 more
Beth Israel Deaconess Medical Center 155
Early research (Phase 1)Study completedNCT00946335
What this trial is testing

ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS Tumors

Who this might be right for
Childhood Atypical Teratoid/Rhabdoid TumorChildhood Central Nervous System Germ Cell TumorChildhood Choroid Plexus Tumor+25 more
National Cancer Institute (NCI) 31
Next Page